从复杂矩阵中识别多巴胺受体连接体,使用循环四甲
Hongyu Wen1, Zhisheng Lai1, Jinhui Wang1
1MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, LIFM, KLGHEI of Environment and Energy Chemistry, School of Chemistry, IGCME, Sun Yat-sen University, Guangzhou, Guangdong 510006, China.
研究人员开发了一种循环四甲 (CP1) 来识别复杂样本中的多巴胺受体配体. 这种方法成功地检测到地下水中的β-乙烯胺,并确定了多巴胺受体D1.1的新对手.
科学领域:
- 生物化学 生物化学
- 分析化学 分析化学
- 药理学 药理学是指药理学的学科.
背景情况:
- G蛋白结合受体 (GPCR) 是关键的药物标,但由于受体不稳定性和复杂的样本矩阵,识别它们的配体具有挑战性.
- 传统的GPCR配体鉴定方法往往是繁和低效的.
研究的目的:
- 开发一种新型的,立体选择性循环四甲 (CP1) 以有效和准确地识别GPCR配体.
- 克服传统的基于受体的方法在连接体发现的局限性.
主要方法:
- 开发一种能够识别共享连接体支架的立体选择性循环四甲 (CP1).
- 在线合CP1与液态染色学,以减少矩阵复杂性.
- 利用高质谱分辨率和可预测的质量-电荷比率转移来识别连接体.
主要成果:
- CP1成功地从复杂矩阵中识别了多巴胺 (DA) 受体连接体.
- 在地下水中首次鉴定出β-phenylethylamine (β-PEA),一种DA受体激动剂.
- 鉴定出1-phenylguanidine (PG) 和1,3-diphenylguanidine (DPG) 是多巴胺受体D1 (DRD1) 的对抗剂.
结论:
- 以CP1为例的寡体,代表了用于GPCR配体发现的气相分子工具的转化类.
- 开发的方法有效地克服了与传统的基于受体的方法相关的瓶.
- 这些发现引发了人们对已识别的化合物对人类多巴胺受体的潜在意外影响的担忧.
更多相关视频
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
09:03Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay
Published on: March 10, 2020
相关概念视频
Golgi Matrix Proteins
One of the first identified Golgi matrix proteins was GM130, a rod-like protein located in the cis-Golgi. Subsequently, many Golgi...
Multi-pass Transmembrane Proteins and β-barrels
α-Helix containing multi-pass transmembrane proteins
Multi-pass transmembrane proteins such as G-protein-linked receptors (GPCRs) and...
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Transducer Mechanism: G Protein–Coupled Receptors
GPCRs are also called heptahelical, 7TM, or...
